vs
Kosmos Energy Ltd.（KOS）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Kosmos Energy Ltd.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.4倍（$294.6M vs $207.3M），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -25.9%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -16.5%）
科斯莫斯能源是一家美国上游石油企业，总部位于得克萨斯州达拉斯。公司目前在加纳、赤道几内亚近海以及墨西哥湾开展油气生产与开发业务，在毛里塔尼亚、塞内加尔近海拥有开发项目，还在纳米比亚、圣多美和普林西比、苏里南近海持有勘探许可。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
KOS vs RARE — 直观对比
营收规模更大
KOS
是对方的1.4倍
$207.3M
营收增速更快
RARE
高出51.8%
-25.9%
两年增速更快
RARE
近两年复合增速
-16.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $294.6M | $207.3M |
| 净利润 | — | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | -125.7% | -54.7% |
| 净利率 | — | -62.0% |
| 营收同比 | -25.9% | 25.9% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $-0.80 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KOSRARE
| Q4 25 | $294.6M | $207.3M | ||
| Q3 25 | $311.0M | $159.9M | ||
| Q2 25 | $392.6M | $166.5M | ||
| Q1 25 | $290.1M | $139.3M | ||
| Q4 24 | $397.6M | $164.6M | ||
| Q3 24 | $407.8M | $139.5M | ||
| Q2 24 | $447.8M | $147.0M | ||
| Q1 24 | $422.3M | $108.8M |
净利润KOSRARE
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $-124.3M | $-180.4M | ||
| Q2 25 | $-87.7M | $-115.0M | ||
| Q1 25 | $-110.6M | $-151.1M | ||
| Q4 24 | — | $-133.2M | ||
| Q3 24 | $45.0M | $-133.5M | ||
| Q2 24 | $59.8M | $-131.6M | ||
| Q1 24 | $91.7M | $-170.7M |
营业利润率KOSRARE
| Q4 25 | -125.7% | -54.7% | ||
| Q3 25 | -34.2% | -106.9% | ||
| Q2 25 | -16.2% | -64.8% | ||
| Q1 25 | -32.4% | -102.6% | ||
| Q4 24 | -8.5% | -74.3% | ||
| Q3 24 | 26.1% | -94.6% | ||
| Q2 24 | 30.2% | -79.1% | ||
| Q1 24 | 33.6% | -151.9% |
净利率KOSRARE
| Q4 25 | — | -62.0% | ||
| Q3 25 | -40.0% | -112.8% | ||
| Q2 25 | -22.3% | -69.0% | ||
| Q1 25 | -38.1% | -108.5% | ||
| Q4 24 | — | -80.9% | ||
| Q3 24 | 11.0% | -95.7% | ||
| Q2 24 | 13.3% | -89.5% | ||
| Q1 24 | 21.7% | -156.8% |
每股收益（稀释后）KOSRARE
| Q4 25 | $-0.80 | $-1.28 | ||
| Q3 25 | $-0.26 | $-1.81 | ||
| Q2 25 | $-0.18 | $-1.17 | ||
| Q1 25 | $-0.23 | $-1.57 | ||
| Q4 24 | $0.00 | $-1.34 | ||
| Q3 24 | $0.09 | $-1.40 | ||
| Q2 24 | $0.12 | $-1.52 | ||
| Q1 24 | $0.19 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $91.5M | $421.0M |
| 总债务越低越好 | $3.1B | — |
| 股东权益账面价值 | $528.6M | $-80.0M |
| 总资产 | $4.7B | $1.5B |
| 负债/权益比越低杠杆越低 | 5.78× | — |
8季度趋势，按日历期对齐
现金及短期投资KOSRARE
| Q4 25 | $91.5M | $421.0M | ||
| Q3 25 | $64.0M | $202.5M | ||
| Q2 25 | $51.7M | $176.3M | ||
| Q1 25 | $49.8M | $127.1M | ||
| Q4 24 | $85.0M | $174.0M | ||
| Q3 24 | $51.6M | $150.6M | ||
| Q2 24 | $173.8M | $480.7M | ||
| Q1 24 | $254.3M | $112.3M |
总债务KOSRARE
| Q4 25 | $3.1B | — | ||
| Q3 25 | $3.0B | — | ||
| Q2 25 | $2.9B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.7B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益KOSRARE
| Q4 25 | $528.6M | $-80.0M | ||
| Q3 25 | $898.8M | $9.2M | ||
| Q2 25 | $1.0B | $151.3M | ||
| Q1 25 | $1.1B | $144.2M | ||
| Q4 24 | $1.2B | $255.0M | ||
| Q3 24 | $1.2B | $346.8M | ||
| Q2 24 | $1.1B | $432.4M | ||
| Q1 24 | $1.1B | $140.3M |
总资产KOSRARE
| Q4 25 | $4.7B | $1.5B | ||
| Q3 25 | $5.1B | $1.2B | ||
| Q2 25 | $5.2B | $1.3B | ||
| Q1 25 | $5.3B | $1.3B | ||
| Q4 24 | $5.3B | $1.5B | ||
| Q3 24 | $5.5B | $1.5B | ||
| Q2 24 | $5.4B | $1.6B | ||
| Q1 24 | $5.4B | $1.3B |
负债/权益比KOSRARE
| Q4 25 | 5.78× | — | ||
| Q3 25 | 3.31× | — | ||
| Q2 25 | 2.80× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.29× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.3M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
经营现金流KOSRARE
| Q4 25 | $35.3M | $-99.8M | ||
| Q3 25 | $-27.6M | $-91.4M | ||
| Q2 25 | $127.2M | $-108.3M | ||
| Q1 25 | $-888.0K | $-166.5M | ||
| Q4 24 | $175.7M | $-79.3M | ||
| Q3 24 | $6.3M | $-67.0M | ||
| Q2 24 | $223.7M | $-77.0M | ||
| Q1 24 | $272.6M | $-190.7M |
自由现金流KOSRARE
| Q4 25 | — | $-100.8M | ||
| Q3 25 | — | $-92.7M | ||
| Q2 25 | — | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | — | $-68.6M | ||
| Q2 24 | — | $-79.0M | ||
| Q1 24 | — | $-193.9M |
自由现金流率KOSRARE
| Q4 25 | — | -48.6% | ||
| Q3 25 | — | -58.0% | ||
| Q2 25 | — | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | — | -49.2% | ||
| Q2 24 | — | -53.7% | ||
| Q1 24 | — | -178.2% |
资本支出强度KOSRARE
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 3.0% |
现金转化率KOSRARE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 3.74× | — | ||
| Q1 24 | 2.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KOS
| Ghana Segment | $134.6M | 46% |
| Gulf Of America | $80.7M | 27% |
| Mauritania And Senegal | $54.9M | 19% |
| Equatorial Guinea Segment | $24.3M | 8% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
